{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.56","upperLimit":"46.00","value":"14.98"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"}],"units":"Participants"}],"description":"Number of months between the first dose date and the date of first disease progression or death as a result of any cause, whichever comes first.","dispersionType":"Full Range","groups":[{"description":"pemetrexed: 500 mg/m2, intravenous, every 21 days x 4 cycles cisplatin: 75 mg/m2, intravenous, every 21 days x 4 cycles chemotherapy, surgery then chest radiation x 54 gray (Gy)","id":"OG000","title":"Pemetrexed"}],"paramType":"MEAN","populationDescription":"All participants who had undergone surgery.","reportingStatus":"POSTED","timeFrame":"baseline to measured progressive disease","title":"Time to Progressive Disease","type":"SECONDARY","unitOfMeasure":"months"}